Peter J. Eggenhuizen

Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease.

Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease.

Journal: International journal of molecular sciences

Published: December 26, 2025

Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease.

Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease.

Journal: International journal of molecular sciences

Published: December 16, 2025

Risk factors for severe infections during induction therapy of patients with microscopic polyangiitis.

Risk factors for severe infections during induction therapy of patients with microscopic polyangiitis.

Journal: Clinical and experimental rheumatology

Published: November 19, 2025

Regulatory T cell therapies: from patient data to biological insights.

Regulatory T cell therapies: from patient data to biological insights.

Journal: Frontiers in immunology

Published: July 28, 2025

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen.

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen.

Journal: Kidney international

Published: May 17, 2024

Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study.

Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study.

Journal: Clinical kidney journal

Published: March 01, 2024

The Influence of Cross-Reactive T Cells in COVID-19.

The Influence of Cross-Reactive T Cells in COVID-19.

Journal: Biomedicines

Published: January 28, 2024

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA.

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA.

Journal: Clinical and experimental medicine

Published: December 27, 2023

Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy.

Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy.

Journal: International immunopharmacology

Published: August 16, 2023

Smith-specific regulatory T cells halt the progression of lupus nephritis.

Smith-specific regulatory T cells halt the progression of lupus nephritis.

Journal: Nature communications

Published: March 12, 2023

Sex disparities in clinicopathological features and outcomes of patients with myeloperoxidase-ANCA-associated vasculitis: a retrospective study of 366 cases in a single Chinese center.

Sex disparities in clinicopathological features and outcomes of patients with myeloperoxidase-ANCA-associated vasculitis: a retrospective study of 366 cases in a single Chinese center.

Journal: Clinical and experimental medicine

Published: November 16, 2022

Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study.

Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study.

Journal: Frontiers in immunology

Published: October 30, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026